Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mads H Rasmussen

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
BMC Genomics|October 18, 2011
Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysisKasper Thorsen, Troels Schepeler, Bodil Øster, et al.
Nature|August 1, 2014
Putative cis-regulatory drivers in colorectal cancerHalit Ongen, Claus L Andersen, Jesper B Bramsen, et al.
Molecular Oncology|March 20, 2013
High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancerMads H Rasmussen, Niels F Jensen, Line S Tarpgaard, et al.
International Journal of Cancer|January 3, 2013
MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancerLise Lotte Christensen, Heidi Tobiasen, Anja Holm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2025
Timing of ctDNA Analysis Aimed at Guiding Adjuvant Treatment in Colorectal CancerTenna V Henriksen, Christina Demuth, Amanda Frydendahl, et al.
Molecular Oncology|September 8, 2017
A genetically inducible porcine model of intestinal cancerMorten M Callesen, Sigrid S Árnadóttir, Iben Lyskjaer, et al.
Molecular Oncology|March 12, 2015
Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistanceNiels F Jensen, Jan Stenvang, Mette K Beck, et al.
Plos One|June 4, 2014
Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancerLise Lotte Christensen, Anja Holm, Juha Rantala, et al.
Cancer Research|September 28, 2014
Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic propertiesMarie Stampe Ostenfeld, Dennis K Jeppesen, Jens R Laurberg, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2024
Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patientsAmanda Frydendahl, Jesper Nors, Mads H Rasmussen, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
BMC Genomics|October 18, 2011
Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysisKasper Thorsen, Troels Schepeler, Bodil Øster, et al.
Nature|August 1, 2014
Putative cis-regulatory drivers in colorectal cancerHalit Ongen, Claus L Andersen, Jesper B Bramsen, et al.
Molecular Oncology|March 20, 2013
High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancerMads H Rasmussen, Niels F Jensen, Line S Tarpgaard, et al.
International Journal of Cancer|January 3, 2013
MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancerLise Lotte Christensen, Heidi Tobiasen, Anja Holm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2025
Timing of ctDNA Analysis Aimed at Guiding Adjuvant Treatment in Colorectal CancerTenna V Henriksen, Christina Demuth, Amanda Frydendahl, et al.
Molecular Oncology|September 8, 2017
A genetically inducible porcine model of intestinal cancerMorten M Callesen, Sigrid S Árnadóttir, Iben Lyskjaer, et al.
Molecular Oncology|March 12, 2015
Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistanceNiels F Jensen, Jan Stenvang, Mette K Beck, et al.
Plos One|June 4, 2014
Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancerLise Lotte Christensen, Anja Holm, Juha Rantala, et al.
Cancer Research|September 28, 2014
Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic propertiesMarie Stampe Ostenfeld, Dennis K Jeppesen, Jens R Laurberg, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2024
Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patientsAmanda Frydendahl, Jesper Nors, Mads H Rasmussen, et al.
Pageof 2